(Hypertension. 2001;38:597.)
© 2001 American Heart Association, Inc.
Cardiovascular Biology |
From the Department of Biological Sciences, School of Medicine of Triângulo Mineiro (V.J.D.d.S., P.C.C.V., R.d.M.A., R.F.), Uberaba, MG, Brazil; Department of Physiology, School of Medicine of Ribeirão Preto USP (H.C.S.), Ribeirão Preto SP, Brazil; and Centro Ricerche Cardiovascolari, CNR, Dipartimento di Scienze Precliniche, L.I.T.A. di Vialba, Medicina Interna II, Ospedale L. Sacco, Universita degli Studi di Milano (N.M.), Milano, Italy.
Correspondence to Valdo José Dias da Silva, MD, PhD, Department of Biological Sciences, School of Medicine of the Triângulo Mineiro, Praça Manoel Terra, 330, Uberaba, MG 38015-050, Brazil. E-mail valdo{at}mednet.com.br
Abstract
Abstract The antihypertensive effect of amiodarone was investigated in spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). The SHR and WKY were treated with amiodarone (1 mg/mL PO) or tap water (control) for 20 weeks. The indirect arterial pressure (AP) was monitored weekly using the tail-cuff method. At the end of the 20th week, the direct AP was measured, and the systolic AP and pulse interval time series were submitted to autoregressive spectral analysis. In addition, cardiac baroreflex sensitivity and left ventricular weight were evaluated as well. The indirect AP was reduced 1 week after the beginning of amiodarone treatment. The direct mean AP and pulse interval were, respectively, 135±8 mm Hg and 191±3 ms in SHR treated with amiodarone (187±8 mm Hg and 156±7 ms in control SHR, P<0.05) and 87±3 mm Hg and 207±8 ms in WKY treated with amiodarone (105±8 mm Hg and 174±4 ms in control WKY, P<0.05). In SHR treated with amiodarone, the low-frequency oscillations of AP were lower (8.5±1.2 mm Hg2 versus 14.4±2.9 mm Hg2 in control SHR, P<0.05), whereas the reflex bradycardia was higher (0.84±0.12 ms/mm Hg versus 0.32±0.22 ms/mm Hg in control SHR, P<0.05). The left ventricle weight was also smaller in SHR treated with amiodarone (2.94±0.12 mg/g versus 3.45±0.24 mg/g in control SHR, P<0.05). In WKY, amiodarone induced similar changes as in SHR, except for a lack of effect in the left ventricle weight. These data indicate that amiodarone has an antihypertensive action in SHR that is associated with a reduction in vasomotor sympathetic modulation, an increase in vagal cardiac baroreflex sensitivity, and a decrease in cardiac hypertrophy.
Key Words: antiarrhythmic agent sympathetic nervous system autonomic nervous system baroreceptors
This article has been cited by other articles:
![]() |
V. Farah, K. M. Elased, and M. Morris Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1083 - H1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Wichi, V. Farah, Y. Chen, M. C. Irigoyen, and M. Morris Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1184 - R1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tachikawa, M. Kodama, K. Watanabe, T. Takahashi, M. Ma, T. Kashimura, M. Ito, S. Hirono, Y. Okura, K. Kato, et al. Amiodarone Improves Cardiac Sympathetic Nerve Function to Hold Norepinephrine in the Heart, Prevents Left Ventricular Remodeling, and Improves Cardiac Function in Rat Dilated Cardiomyopathy Circulation, February 22, 2005; 111(7): 894 - 899. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |